A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Public ClinicalTrials.gov record NCT05936151. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Double-Blind Study to Investigate the Effect of Retatrutide on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Study identification
- NCT ID
- NCT05936151
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 146 participants
Conditions and interventions
Conditions
Interventions
- Retatrutide Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 19, 2023
- Primary completion
- Sep 30, 2025
- Completion
- Oct 20, 2025
- Last update posted
- Nov 24, 2025
2023 – 2025
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Institute for Liver Health II dba Arizona Clinical Trials - Mesa | Chandler | Arizona | 85225 | — |
| Care Access - 801 South Power Road, Mesa | Mesa | Arizona | 85206 | — |
| Headlands Research - Scottsdale | Scottsdale | Arizona | 85260 | — |
| Medical Advancement Centers of Arizona | Tempe | Arizona | 85283 | — |
| Hope Clinical Research, Inc. | Canoga Park | California | 91303 | — |
| Catalina Research Institute, LLC | Montclair | California | 91763 | — |
| Peninsula Research Associates | Rolling Hills Estates | California | 90274 | — |
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | — |
| Teradan Clinical Trials, LLC | Brandon | Florida | 33511 | — |
| Suncoast Clinical Research, Inc. | New Port Richey | Florida | 34652 | — |
| Great Lakes Clinical Trials - Ravenswood | Chicago | Illinois | 60640 | — |
| Indiana University Health University Hospital | Indianapolis | Indiana | 46202 | — |
| Prime Health and Wellness/SKYCRNG | Fayette | Mississippi | 39069 | — |
| Palm Research Center Tenaya | Las Vegas | Nevada | 89128 | — |
| NYU Langone Hospital - Long Island | Mineola | New York | 11501 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Victorium Clinical Research - Houston | Houston | Texas | 77024 | — |
| Endocrine Ips, Pllc | Houston | Texas | 77079 | — |
| Tranquility Research | Webster | Texas | 77598 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05936151, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 24, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05936151 live on ClinicalTrials.gov.